Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study

BACKGROUND: Estimating quality of life (QoL) in patients with breast cancer is of importance in assessing treatment outcomes. Adjuvant endocrine therapy is widely used for hormone receptor-positive (HR+) early-stage breast cancer (EBC), and evidence suggests that aromatase inhibitors (AIs) may impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ayong, Zhang, Jin, Liu, Xiaoan, Wu, Weizhu, Liu, Yinhua, Fan, Zhimin, Zhang, Anqin, Zhou, Tianning, Fu, Peifen, Wang, Shu, Ouyang, Quchang, Tang, Jinhai, Jiang, Hongchuan, Zhang, Xiaohua, Pang, Da, He, Jianjun, Shi, Linxiang, Wang, Xianming, Sheng, Yuan, Mao, Dahua, Shao, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806477/
https://www.ncbi.nlm.nih.gov/pubmed/27009092
http://dx.doi.org/10.1186/s12955-016-0446-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806477/
https://www.ncbi.nlm.nih.gov/pubmed/27009092
http://dx.doi.org/10.1186/s12955-016-0446-2

Ejemplares similares